Latest News

HKEX Launches Artificial Intelligence and Semiconductor Indices

* Launch of HKEX Artificial Intelligence Index and HKEX Semiconductor Index to provide benchmarks for two key technology themes * HKEX continues to expand proprietary index suite and broaden coverage of emerging technology trends * License agreement with Southern Asset Management to issue ET...

2026-10-26 13:49 5630

Newborn Town and Viggle Launch AI-Powered 3D Interactive Game, Bringing World Models to Social Gaming

HONG KONG, Oct. 26, 2026 /PRNewswire/ -- Recently, Newborn Town's game-oriented social platform TopTop has launched "Slap Showdown", an AI-powered 3D interactive mini-game developed in collaboration with Viggle, a company specializing in physics-native world models. The launch brings world model ...

2026-10-26 12:00 9876

Direct Life Education partners Care Corner Seniors Services to launch new community initiative to help seniors leave a legacy through life stories

SINGAPORE, Oct. 26, 2026 /PRNewswire/ -- Direct Life Education, the education and advisory arm of Direct Funeral Services (DFS), partners Care Corner Seniors Services to launch My Story, My Life, a new free community initiative designed to help seniors reflect on their lives, capture meaningful m...

2026-10-26 11:43 2931

ESMO 2026 | Professors Jie Wang, Zhijie Wang and Jianchun Duan's Team Reports 95.2% Disease Control With LK101 Combination Maintenance Therapy in Advanced NSCLC

BEIJING, Oct. 25, 2026 /PRNewswire/ -- On October 24, 2026, in Madrid, Spain, the team of Professors Jie Wang, Zhijie Wang and Jianchun Duan at the Cancer Hospital, Chinese Academy of Medical Sciences, presented Phase 1b/2a results in a Rapid Oral session at ESMO Congress 2026. The study evaluate...

2026-10-26 11:27 3363

World‑class Drivers Gather, Domestic Titles Decided | CTCC Shaoxing Keqiao Round Concludes Successfully

SHAOXING, China, Oct. 26, 2026 /PRNewswire/ -- On October 25, the second race day unfolded for the 2026 FIA TCR World Tour together with the Xiaomi‑sponsored CTCC China Touring Car Championship at the Shaoxing Keqiao Round. Four major competitions — the FIA TCR World Tour, TCR Asia Championship‑A...

2026-10-26 11:16 3120

Delixi Electric at the 140th Canton Fair Expanding Solutions Strengthening Global Partnerships

GUANGZHOU, China, Oct. 26, 2026 /PRNewswire/ -- The 140th China Import and Export Fair, widely known as the Canton Fair, opened in Guangzhou on October 15, 2026, marking the event's 70th anniversary. Delixi Electric returned with an expanded portfolio spanning power distribution, industrial contr...

2026-10-26 11:00 2923

Xinhua Silk Road: North Bund Forum deepens consensus on win-win shipping cooperation

BEIJING, Oct. 26, 2026 /PRNewswire/ -- When the 2026 North Bund Forum was held in Shanghai recently, around 4,000 participants gathered at the North Bund to build deeper consensus on global shipping win-win cooperation.

2026-10-26 10:58 2022

fileAI Signs Strategic Collaboration Agreement with AWS to Accelerate Rollout of Outcome-Driven AI Agents for BFSI Leaders

SINGAPORE, Oct. 26, 2026 /PRNewswire/ -- fileAI announced a strategic collaboration agreement (SCA) with Amazon Web Services, Inc. (AWS) to bring a new suite of AI agents to banking, financial services, and insurance (BFSI) leaders—built to complete critical operational workflows, not just assist...

2026-10-26 10:00 6003

A Major Breakthrough in Smart Insurance Education: HK Insurance Hub Leverages AI Content Optimization to Demystify Protection for Hong Kong Citizens

HONG KONG, Oct. 26, 2026 /PRNewswire/ -- With the vast array of insurance products available and their often lengthy, complex terms, many citizens feel overwhelmed when choosing coverage. To advance public insurance education in Hong Kong, local insurance information hubHK Insurance Hub

2026-10-26 10:00 3891

Beyond the Label of Solo Motherhood: TECNO and Angélica Dass Launch the Philippines Portrait Gallery for 100 Portraits of Becoming

The gallery brings together 20 Filipinos whose lives intersect with solo motherhood, revealing the diverse roles, relationships and ambitions that extend far beyond a single label. MANILA, Philippines, Oct. 26, 2026 /PRNewswire/ -- TECNO and internationally acclaimed artist Angélica Dass unveile...

2026-10-26 10:00 3883

SSI SCHAEFER's Four-Way Pallet Roaming Shuttle Is Expanding Warehouse Design Possibilities

SEOUL, South Korea, Oct. 26, 2026 /PRNewswire/ -- For warehouse operators in South Korea, warehouse design is increasingly shaped by competing demands: making better use of available space, managing labor constraints and maintaining reliable operations without committing to automation that exceed...

2026-10-26 09:30 2423

Syfe Launches Yield+ in Hong Kong to Make Locals' Savings Work Harder

The new HKD portfolio is designed for money set aside for 12 months or more, with no lock-in and no minimum investment HONG KONG, Oct. 26, 2026 /PRNewswire/ -- Syfe, the Singapore-headquartered digital wealth platform managing over US$15 billion in assets across Asia-Pacific, today announced the...

2026-10-26 09:01 3079

Tin Men Capital leads US$7.4M Series A for Vision AI startup Ailytics to expand across APAC, US and Gulf

SINGAPORE, Oct. 26, 2026 /PRNewswire/ -- Ailytics , a vision AI startup that turns existing industrial CCTV into a real-time safety and operations layer, has raised US$7.4 million in a Series A led by Tin Men Capital. SEEDS, part of SG Growth Capital, Safie, Japan's larg...

2026-10-26 09:00 7126

Results of CARsgen's Satri-cel for Adjuvant Treatment for Gastric Cancer Presented at ESMO Congress 2026

SHANGHAI, Oct. 25, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the preliminary positive research results of the investigator-initiated trial (CT041-CG4010, NCT06857786) in China o...

2026-10-26 08:30 5895

Ascletis Announces FDA IND Submission of ASC39, an Oral Small Molecule Selective Amylin Receptor Agonist for the Treatment of Obesity

- ASC39, an oral small molecule selective amylin receptor agonist, demonstrated eloralintide-like amylin selectivity and efficacy in preclinical models. - ASC39 demonstrated eloralintide-like selectivity for human amylin 1 receptor (hAMY1R) over human calcitonin receptor (hCTR) (40-fold), support...

2026-10-26 08:10 6275

26th Shanghai Fair Returns to Kuala Lumpur to Strengthen Trade and Cultural Ties

KUALA LUMPUR, Malaysia, Oct. 26, 2026 /PRNewswire/ -- The 26th Shanghai Fair Trade Show – Malaysia,organized by RCG International Convention & Exhibition Co. Limited, will take place on 16–17 November 2026 at the Malaysia International Trade and Exhibition Centre (MITEC), Kuala Lumpur, bringing ...

2026-10-26 08:00 2476

Antengene Presents Latest Clinical Results for ATG-022 and ATG-037 at ESMO 2026

SHANGHAI and HONG KONG, Oct. 26, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune dis...

2026-10-26 08:00 2538

uSMART and PIVOT Fintech Introduce GlobalSave Portfolios Balanced Strategy on FollowSmart

SINGAPORE, Oct. 26, 2026 /PRNewswire/ -- uSMART Securities (Singapore) Pte. Ltd. ("uSMART") has announced the addition of thePIVOT- GlobalSave Portfolios Balanced Strategy to its FollowSmart platform. Managed by PIVOT Fintech Pte. Ltd. ("PIVOT"), the strategy is being made available through uSMAR...

2026-10-26 08:00 1994

RIMAN Connects Global Direct Selling Leaders with K-Beauty Innovation Through WFDSA World Congress and Jeju Experience Tour

* RIMAN participated as a Platinum Sponsor of the 18th WFDSA World Congress, highlighting its proprietary ingredients and R&D capabilities * The company hosted 24 direct selling industry representatives from nine countries for an exclusive brand experience on Jeju Island SEOUL, South Korea, O...

2026-10-26 08:00 4344

2026 ESMO | Innovent Presents Multiple Clinical Data Updates for IBI363/TAK-928, a PD-1/Alpha-Biased IL-2 Bispecific Fusion Protein

* The data showcased are from three Phase 1b clinical studies of IBI363/TAK-928 in first-line NSCLC, first-line G/GEJA, and immunotherapy-resistant lung adenocarcinoma, further supporting its potential clinical value across treatment settings. SAN FRANCISCO and SUZHOU, China, Oct. 25, 2026 /PR...

2026-10-26 08:00 3979
1 ... 23242526272829 ... 5530

Week's Top Stories